List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 1665 studies with search of:   Denmark
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Prospective Evaluation of Proteinuria and Renal Function in Non-Diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
2 Completed Safety Study of Apixaban in Recent Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Interventions: Drug: Apixaban;   Drug: Apixaban;   Drug: Placebo
3 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
4 Completed Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography (ERCP) Pancreatitis?
Condition: Pancreatitis
Intervention: Drug: glyceryl nitrate
5 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
6 Completed Chest Pain Pilot Study
Conditions: Chest Pain;   Gastroesophageal Reflux
Intervention: Drug: Esomeprazole
7 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
8 Completed To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
Condition: Alzheimer's Disease
Intervention: Drug: Atorvastatin
9 Completed A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention
Condition: Coronary Heart Disease
Intervention: Drug: SB-681323
10 Recruiting Study of Apixaban for the Prevention of Thrombosis-Related Events in Patients With Acute Medical Illness
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Apixaban;   Drug: Enoxaparin
11 Not yet recruiting Anti-Interleukin-1 in Diabetes Action
Condition: Type 1 Diabetes
Interventions: Drug: anakinra;   Drug: saline
12 Completed A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines
Condition: Extravasation
Intervention: Drug: Dexrazoxane
13 Recruiting Discontinuation of TNF-Alpha Inhibitors in Patients With Spondyloarthritis
Condition: Spondyloarthritis
Intervention: Drug: Discontinuation of TNF-alpha inhibitor and re-starting it if flare-up in disease activity (etanercept or adalimumab)
14 Completed RE-MODEL Dabigatran Etexilate 150mg or 220mg o.d vs. Enoxaparin 40mg o.d for Prevention of Thrombosis After Knee Surgery
Conditions: Arthroplasty, Replacement, Knee;   Thromboembolism
Interventions: Drug: "Dabigatran etexilate (oral, 150 mg once daily)";   Drug: "Enoxaparin (subcutaneous, 40 mg once daily)";   Drug: "Dabigatran etexilate (oral, 220 mg once daily)"
15 Active, not recruiting Study to Assess the Safety of CDP870 for up to 30 Months Following Reintroduction of Treatment
Condition: Crohn's Disease
Intervention: Biological: CDP870
16 Completed Crestor Versus Placebo in Subjects With Heart Failure
Condition: Heart Failure
Intervention: Drug: rosuvastatin
17 Completed MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults
Condition: Asthma
Interventions: Drug: Budesonide/Formoterol Turbuhaler;   Drug: Conventional Best Asthma Therapy
18 Recruiting Efficacy of Bortezomib Consolidation After High-Dose Melphalan With Stem Cell Support in Myeloma Patients
Condition: Multiple Myeloma
Intervention: Drug: bortezomib
19 Recruiting Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: Thalidomide
20 Completed A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter
Condition: Atrial Flutter
Intervention: Drug: Vernakalant Injection 20 mg/mL

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services